TAF has a higher risk of hypertension than TDF, according to an HIV pre-exposure prophylaxis study.

Published Date: 20 Sep 2023

Tenofovir alafenamide fumarate (TAF) use was linked to more instances of hypertension in patients receiving pre-exposure prophylaxis (PrEP), according to research from Kaiser Permanente Southern California, Pasadena.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

2.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

3.

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

4.

Charles III, King of Kings, is Cancerous.

5.

The Truth About Apple AirPods


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot